Risk factors for post-ERCP pancreatitis: A systematic review of clinical trials with a large sample size in the past 10 years

European Journal of Medical Research

Volumn 19, Issue 1, 2014, Pages

  Chen, Jian Jun ^a,b   Wang, Xi Mo ^a,b   Liu, Xing Qiang ^b   Li, Wen ^b   Dong, Mo ^b   Suo, Zong Wu ^b   Ding, Po ^b   Li, Yue ^b  

^a TIANJIN NANKAI HOSPITAL   (China)

^b People's Hospital of Tianjin   (China)

Author keywords

Endoscopic retrograde cholangiopancreatography; Pancreatitis; Risk factors; Systematic review

Indexed keywords

ABDOMINAL PAIN; ARTICLE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; HUMAN; MEDLINE; PANCREAS DUCT; PANCREATIC DUCT STENT; PANCREATITIS; POSTENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS; PUBLICATION; QUALITY CONTROL; RISK FACTOR; SAMPLE SIZE; SPHINCTEROTOMY; SYSTEMATIC REVIEW; VATER PAPILLA STENOSIS; CLINICAL TRIAL (TOPIC); FEMALE; MALE; REVIEW;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE; PANCREATITIS; RISK FACTORS;

EID: 84901691314     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-19-26     Document Type: Article

References (31)

1. Feasibility of endoscopic retrograde cholangiopancreatographyrelated procedures in hemodialysis patients. Hori Y, Naitoh I, Nakazawa T, Hayashi K, Miyabe K, Shimizu S, Kondo H, Yoshida M, Yamashita H, Umemura S, Ban T, Okumura F, Sano H, Takada H, Joh T, J Gastroenterol Hepatol 2014 29 648 652 10.1111/jgh.12336 23869844
2. Quality indicators, including complications, of ERCP in a community setting: a prospective study. Colton JB, Curran CC, Gastrointest Endosc 2009 70 457 467 10.1016/j.gie.2008.11.022 19482278
3. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Cotton PB, Garrow DA, Gallagher J, Romagnuolo J, Gastrointest Endosc 2009 70 80 88 10.1016/j.gie.2008.10.039 19286178
4. Complications of ERCP. Anderson MA, Fisher L, Jain R, Evans JA, Appalaneni V, Ben-Menachem T, Cash BD, Decker GA, Early DS, Fanelli RD, Gastrointest Endosc 2012 75 467 473 10.1016/j.gie.2011.07.010 22341094
5. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, Overby CS, Aas J, Ryan ME, Bochna GS, Gastrointest Endosc 2001 54 425 434 10.1067/mge.2001.117550 11577302 (Pubitemid 33661145)
6. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano MR, Spirito F, Pilotto A, Forlano R, Am J Gastroenterol 2007 102 1781 1788 10.1111/j.1572-0241.2007.01279.x 17509029 (Pubitemid 47206695)
7. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Masci E, Mariani A, Curioni S, Testoni PA, Endoscopy 2003 35 830 834 14551860 (Pubitemid 37254216)
8. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ, Control Clin Trials 1996 17 1 12 10.1016/0197-2456(95) 00134-4 8721797 (Pubitemid 26120810)
9. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Andriulli A, Clemente R, Solmi L, Terruzzi V, Suriani R, Sigillito A, Leandro G, Leo P, De Maio G, Perri F, Gastrointest Endosc 2002 56 488 495 10.1016/S0016-5107(02)70431-8 12297762
10. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Andriulli A, Solmi L, Loperfido S, Leo P, Festa V, Belmonte A, Spirito F, Silla M, Forte G, Terruzzi V, Clin Gastroenterol Hepatol 2004 2 713 718 10.1016/S1542-3565(04)00295-2 15290665 (Pubitemid 39013432)
11. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL, Am J Gastroenterol 2006 101 139 147 10.1111/j.1572-0241.2006.00380.x 16405547 (Pubitemid 43381722)
12. Risk factors for acute pancreatitis induced by ERCP. Xia YZY, Yu JW, Zhang B, Chin J Dig Endosc 2004 10 78 84
13. Are drugs a risk factor of post-ERCP pancreatitis? Perney P, Berthier E, Pageaux GP, Hillaire-Buys D, Roques V, Fabbro-Peray P, Melki M, Hanslik B, Bauret P, Larrey D, Gastrointest Endosc 2003 58 696 700 10.1016/S0016-5107(03) 02019-4 14595303 (Pubitemid 37370482)
14. Risk of pancreatitis after endoscopic retrograde cholangiopancreatography and endoscopic biliary drainage. Matsubayashi H, Fukutomi A, Kanemoto H, Maeda A, Matsunaga K, Uesaka K, Otake Y, Hasuike N, Yamaguchi Y, Ikehara H, HPB (Oxford) 2009 11 222 228 10.1111/j.1477-2574.2008.00020.x 19590651
15. Risk factors for post-ERCP pancreatitis in high-and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Testoni PA, Mariani A, Giussani A, Vailati C, Masci E, Macarri G, Ghezzo L, Familiari L, Giardullo N, Mutignani M, Am J Gastroenterol 2010 105 1753 1761 10.1038/ajg.2010.136 20372116
16. Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: prospective singleinstitution study. Tsuyuguchi T, Okugawa T, Yokosuka O, Dig Endosc 2007 19 49 S51 10.1111/j.1443-1661.2007.00737.x (Pubitemid 47084084)
17. Risk factors for complications after performance of ERCP. Vandervoort J, Soetikno RM, Tham TC, Wong RC, Ferrari AP Jr, Montes H, Roston AD, Slivka A, Lichtenstein DR, Ruymann FW, Gastrointest Endosc 2002 56 652 656 10.1016/S0016-5107(02)70112-0 12397271 (Pubitemid 36531698)
18. Biliary stent placement is associated with post-ERCP pancreatitis. Wilcox CM, Phadnis M, Varadarajulu S, Gastrointest Endosc 2010 72 546 550 10.1016/j.gie.2010.05.001 20633882
19. Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases. Zhou W, Li Y, Zhang Q, Li X, Meng W, Zhang L, Zhang H, Zhu K, Zhu X, Pancreatology 2011 11 399 405 10.1016/S1424-3903(11)80094-3 21894057
20. Mechanism of pancreatitis caused by ERCP. Akashi R, Kiyozumi T, Tanaka T, Sakurai K, Oda Y, Sagara K, Gastrointest Endosc 2002 55 50 54 10.1067/mge.2002.118964 11756914 (Pubitemid 41122923)
21. Diagnosis of mild chronic pancreatitis (Cambridge classification): comparative study using secretin injection-magnetic resonance cholangiopancreatography and endoscopic retrograde pancreatography. Sai JK, Suyama M, Kubokawa Y, Watanabe S, World J Gastroenterol 2008 14 1218 1221 10.3748/wjg.14.1218 18300347 (Pubitemid 351356329)
22. Is endoscopic balloon dilation for removal of bile duct stones associated with an increased risk for pancreatitis or a higher rate of hyperamylasemia? Bergman J, van Berkel AM, Bruno M, Fockens P, Rauws E, Tijssen J, Tytgat G, Huibregtse K, Endoscopy 2001 33 416 420 10.1055/s-2001-14424 11396759 (Pubitemid 32586447)
23. Complications of endoscopic biliary sphincterotomy. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ, N Engl J Med 1996 335 909 919 10.1056/NEJM199609263351301 8782497 (Pubitemid 26314443)
24. Risk of pancreatitis following endoscopically placed large-bore plastic biliary stents with and without biliary sphincterotomy for management of postoperative bile leaks. Simmons D, Petersen B, Gostout C, Levy M, Topazian M, Baron T, Surg Endosc 2008 22 1459 1463 10.1007/s00464-007-9643-8 18027045
25. Comparison between emergency and elective endoscopic sphincterotomy in patients with acute cholangitis due to choledocholithiasis: is emergency endoscopic sphincterotomy safe? Ueki T, Otani K, Fujimura N, Shimizu A, Otsuka Y, Kawamoto K, Matsui T, J Gastroenterol 2009 44 1080 1088 10.1007/s00535-009- 0100-4 19597758
26. Complications of endoscopic sphincterotomy: a prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Sherman S, Ruffolo TA, Hawes RH, Lehman GA, Gastroenterology 1991 101 1068 1075 1889699
27. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Fogel EL, Eversman D, Jamidar P, Sherman S, Lehman GA, Endoscopy 2002 34 280 285 10.1055/s-2002-23629 11932782 (Pubitemid 34279515)
28. ERCP cannulation: a review of reported techniques. Freeman ML, Guda NM, Gastrointest Endosc 2005 61 112 125 10.1016/S0016-5107(04)02463-0 15672074 (Pubitemid 40169828)
29. Functional gallbladder and sphincter of oddi disorders. Behar J, Corazziari E, Guelrud M, Hogan W, Sherman S, Toouli J, Gastroenterology 2006 130 1498 1509 10.1053/j.gastro.2005.11.063 16678563
30. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Choudhary A, Bechtold ML, Arif M, Szary NM, Puli SR, Othman MO, Pais WP, Antillon MR, Roy PK, Gastrointest Endosc 2011 73 275 282 10.1016/j.gie.2010.10.039 21295641
31. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Tsujino T, Komatsu Y, Isayama H, Hirano K, Sasahira N, Yamamoto N, Toda N, Ito Y, Nakai Y, Tada M, Clin Gastroenterol Hepatol 2005 3 376 383 10.1016/S1542-3565(04)00671-8 15822043 (Pubitemid 40488346)